SGD Pharma, a leading player in the pharmaceutical packaging industry, is actively taking steps to combat global warming.
In a bold move towards environmental sustainability, SGD Pharma is aligning its efforts to combat global warming on multiple fronts. The company’s decarbonization strategy, with a clear goal of reducing CO2 scope 1 and 2 emissions by 35% in 2030 and an impressive 65% by 2040, compared to 2020 levels, is currently under validation by the Science-Based Targets initiative (SBTi).
One noteworthy initiative that underscores SGD Pharma’s commitment to biodiversity and climate action is its partnership with the Zhanjiang Mangrove Wetland Conservation Federation. SGD Pharma has been invited to join the board of directors for this association, which focuses on promoting the scientific protection, management, and sustainable use of mangrove wetlands. This recognition highlights SGD Pharma’s dedication to preserving the mangrove ecosystem in Zhanjiang, with a commitment to planting 10,000 trees by the end of 2024.
The association’s Chairman, Mr. Liao, joined SGD Pharma at the CCI France Chine event, where discussions on the partnership took place alongside the Director for China at Climate Fresk. This collaborative effort is a testament to SGD Pharma’s proactive approach to environmental conservation.
For those eager to delve deeper into SGD Pharma’s sustainability efforts, the company’s comprehensive sustainability report provides detailed insights into its involvement in mangrove preservation in Zhanjiang.
Source: SGD Pharma with additional information added by Apazone